Nabta Health
Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC). NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes. Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.
Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC). NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes. Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.
Nabta Health has raised $5.5M across 3 rounds. Its most recent round was a Seed of $2.0M in Nov 2025. Full funding history, investors, and team are detailed below.
Funding history
3 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 2 earlier rounds — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Nabta Health is featured in
Similar companies
Qureos is a Learn to Earn marketplace helping people around the world to learn industry relevant skills from the top 1% mentors and unlock job opportunities based on their dynamic learning portfolio. The community creates win-win value to all members: learners, mentors and businesses. Qureos will accelerate careers, provide access to the world class mentors and unlock dream careers for everyone, everywhere.
Amaani is building world-class beauty and wellness brands from the Middle East, starting with its flagship brand AÏZA — premium skincare and haircare inspired by region’s rich ingredients and rituals. AÏZA is rooted in timeless Arab ingredients such as dates, black seed, bakhoor, sidr, frankincense and saffron, combined with clinically proven actives in leading labs in Italy, Japan and South Korea. The result? Clean, alcohol-free, vegan products that offer a luxurious, sensorial experience with superior efficacy.
Next'House is a Dubai-born hostel chain committed to redefining affordable luxury in the hospitality sector. With a portfolio of 178 beds across private and shared accommodations, we deliver exceptional comfort and style at accessible prices, catering primarily to millennials and Gen Z, including digital nomads, students, young entrepreneurs, remote workers and leisure travelers. Our expert team has successfully launched and scaled Next'House over the past two years. As we set our sights on becoming the largest hostel chain in the MENA region, we aim to triple our number of beds by the end of 2025. We are actively seeking new assets and opportunities to expand our footprint and continue providing top-tier experiences for our guests. Connect with us to explore potential collaborations and partnerships. For more information, contact us at management@nexthousedxb.com.
HelloVote is a developer of voter engagement platform simplifying registration, election information, and civic participation.
Los Sundays is a lifestyle brand disrupting a product-focused category. Strategically built to engage organically with consumers through today's most influential channels – social media, fashion, and immersive events. Los Sundays combines original and relatable content with award-winning tequila to captivate and inspire the new generation of tequila consumers.
Women's Health Center of West Virginia is a private nonprofit healthcare facility that provides reproductive and sexual healthcare, gynecologic wellness exams, contraception, STI testing and treatment, and pregnancy confirmation. The organization offers HIV testing and PrEP, chest and cervical cancer screenings, and a harm reduction program. It provides LGBTQIA+ health services, including gender-affirming hormone therapy, and educational resources on abortion options and legal restrictions.
Coast 4C supports sustainable seaweed supply, combining community, commerce, conservation, and climate benefits.
Sportway is an online network that enables young athletes to meet and share experiences.
InterCure is a manufacturer and distributor of pharmaceutical medical cannabis products.
Skiptown (formerly Skipper) is a tech-enabled hub for dogs and their people. The trusted pet services company provides pet parents with first-class dog walking, daycare, and boarding services, as well as a membership-based dog park and bar – all powered by the Skiptown mobile app. Skiptown has secured thousands of members since opening the first location in Charlotte, NC in August of 2020. Skiptown offers an indoor/outdoor turfed dog park, a bar for humans, dog daycare, overnight boarding, a grooming salon, and dog walking services. From valet daycare drop-off to "Skippers" who monitor the pups at play, Skiptown's dog-focused design and high-end hangout is about giving peace of mind to pet parents and joy to their four-legged family members. Skiptown's proprietary technology platform streamlines booking and account management, sends multiple daily visit reports, pairs dogs to playgroups based on personality type, and allows for a fully customized experience for every dog. Backed by private investors and high-profile venture capital firms, including Techstars Ventures, Bull Creek Capital, and Firebrand Ventures, Skiptown is poised for growth. Founded in 2016 and headquartered in Charlotte, N.C., Skiptown is expanding into new markets soon! Learn more about how Skiptown is revolutionizing the pet parent experience at skiptown.io.
June is the foremost complete virtual care platform created to support women at every stage of their health journey, while also acknowledging that women's health and family well-being are inextricably linked.
Nicol is an operator of multi-racquet sports clubs offering fitness and community.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.